Skip to main content
for

Dr. Donald Lloyd-Jones: Faculty Experts

Not seeing the results that match your search? FILTER BY CATEGORY AND FIELD

Dr. Donald Lloyd-Jones

Northwestern University Feinberg School of Medicine

Eileen M. Foell Professor of Heart Research
Professor of Preventive Medicine, Medicine, and Pediatrics
Chair, Department of Preventive Medicine
Senior Associate Dean for Clinical and Translational Research
Director, Northwestern University Clinical and Translational Sciences (NUCATS) Institute

About

Areas of Focus

  • Cardiovascular disease causes
  • Life course of cardiovascular disease
  • Cardiovascular epidemiology
  • Cardiovascular disease treatments - diet, physical activity, drugs
  • Lipids
  • Hypertension
  • Chronic disease prevention

Work/Research

  • Risk assessment for cardiovascular disease
  • Molecular mechanisms of cardiovascular disease
  • Hypertension
  • Cholesterol treatment
  • Population research
  • Prevention of cardiovascular disease

Career

Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. A main focus of his research has been investigation of the life course of chronic diseases of aging, lifetime risks for various cardiovascular diseases and factors that modify those risks. Other areas of interest include CVD risk estimation using novel biomarkers, imaging of subclinical atherosclerosis, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention. He chaired the committee and authored the monograph that defined and set the American Heart Association’s Strategic Impact Goals for 2020 and Beyond, including a bold new focus on cardiovascular health promotion. He was co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and a member of the 2019 Primary Prevention Guidelines Panel. He has authored over 420 peer-reviewed scientific publications to date. Annually from 2014-2019, he has been named by Clarivate Analytics (Thomson Reuters) as a “Highly Cited Researcher,” a distinction reserved for investigators in the top 1% by total citations of highly cited papers in their scientific field (in this case, clinical medicine) during the period 2002-2017. He is a fellow of the American College of Cardiology and the American Heart Association (AHA) and is an inducted member of the American Society for Clinical Investigation and Association of American Physicians. In 2010, he was awarded the AHA’s annual Chairman’s Award, recognizing the volunteer who has performed outstanding service to further the AHA's strategic goals. He also is a recipient of the 2017 Physician of the Year Award from the AHA and the Joseph Stokes, III, MD Award from the American Society for Preventive Medicine. He is a recipient of numerous teaching awards, including the Patterson Award for Teacher of the Year from the Department of Medicine and the Teacher of the Year from the Division of Cardiology at Northwestern. In 2013, he was awarded Northwestern’s Tripartite Legacy Award in recognition of his achievements as a mentor, leader, and translational physician-scientist.